Lilac Insights Revenue and Competitors

Navi Mumbai,

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Lilac Insights's estimated annual revenue is currently $120.2M per year.(i)
  • Lilac Insights's estimated revenue per employee is $337,500

Employee Data

  • Lilac Insights has 356 Employees.(i)
  • Lilac Insights grew their employee count by 3% last year.

Lilac Insights's People

NameTitleEmail/Phone
1
Scientific Officer 4Reveal Email/Phone
2
Head - Lab OperationsReveal Email/Phone
3
Head, Medical Science Liaison, Reproductive GeneticsReveal Email/Phone
4
Head - IT and Digital TransformationReveal Email/Phone
5
DirectorReveal Email/Phone
6
Senior Human Resources ManagerReveal Email/Phone
7
Category Marketing ManagerReveal Email/Phone
8
Senior Lab Admin & Facility ManagerReveal Email/Phone
9
System AdministratorReveal Email/Phone
10
Scientific AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is Lilac Insights?

Lilac Insights is leading as a Genetic Health Assessment & Diagnostic Centre and currently operating in 100+ cities of India with head office and main lab in Mumbai and satellite centers in Bangalore, Pune, Kolkata, and Chandigarh. Lilac Insights laboratory is accredited and certified by ISO, NABL, UK-NEQAS, RIQAS as well as adhere to guidelines set by internationally renowned organization i.e. Fetal Medicine Foundation-FMF (UK), National Health Service (UK). Our Services • Reproductive Genetics Prenatal screening Dual Marker Quad Marker Pre-eclampsia screening Thalassemia screening Clinical Cytogenetics Epitome (Blood karyotyping) Karyotyping on AF/CVS/Cord Blood FISH on AF/CVS/Cord Blood • Molecular Genetics PCR QF-PCR InsighT & InsighT plus (NIPT/NIPS) MLPA for SMA & DMD Fragile X screening • Genomics 1. Sanger Sequencing 2. Microarray: Altum and Altum 750k 3. Clinical Exome 4. Whole Exome 5. Focused Gene Panel 6. Whole Genome sequencing • Oncogenetics • Metabolic Genetics Program 1. Newborn screening (NBS) • Genetic consultation & counseling Prenatal, Premarital, Postnatal, Preconception, Metabolic genetics, and Fetal autopsy

keywords:N/A

N/A

Total Funding

356

Number of Employees

$120.2M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lilac Insights News

2022-04-06 - Importance of prenatal screening to detect down syndrome Express Healthcare

Importance of prenatal screening to detect down syndrome Express Healthcare

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3586%N/A
#2
N/A360-10%N/A
#3
$121.8M36124%N/A
#4
$40.8M36313%N/A
#5
$34.6M38211%N/A